Advertisement

Topics

Banner Alzheimer's Institute Company Profile

20:46 EDT 21st March 2019 | BioPortfolio

Banner Alzheimer's Institute (BAI) is a treatment and research facility dedicated to helping patients with memory and thinking problems. It offers clinical care for patients; provides education, referral and support services for families and caregivers; and conducts leading-edge brain-imaging, clinical trials, brain imaging and genetics studies. The Institute is devoted to finding effective Alzheimer's disease-slowing and prevention treatments in the shortest time possible. BAI is owned and operated by Phoenix-based Banner Health, a nonprofit organization. For more information, visit www.banneralz.org.


News Articles [1899 Associated News Articles listed on BioPortfolio]

Amgen, Novartis and Banner Alzheimer's Institute Team on 2 Alzheimer's Prevention Trials

Again and again … and again, drugs have failed in clinical trials for Alzheimer’s disease. According to a new report, in the last decade, 146 drugs have failed in clinical trials for Alzheimer’s...

Novartis: Weltweit größte Alzheimer-Umfrage zeigt große Bereitschaft zur Teilnahme an klinischen Studien

Basel/Nürnberg (ots) - - Querverweis: Bildmaterial wird über obs versandt und ist abrufbar unter http://www.presseportal.de/bilder - - Novartis, Amgen und Banner Alzheimer's Institute stellen weltw....

Survey: 91% of people around the world believe medical research will result in dementia cure

A new survey from Novartis, Amgen and Banner Alzheimer’s Institute, along with Alzheimer’s Disease International, shows that 91% of people from around the world believe medical research will resul...

Healthy Eating and Alzheimer's Disease

Source: National Institute on Aging - Related MedlinePlus Pages: Alzheimer's Caregivers, Alzheimer's Disease

World’s largest Alzheimer’s survey reveals most adults believe a cure will be developed in their lifetime

18 September 2018 - A new survey released today by Banner Alzheimer’s Institute (BAI), Novartis, and Amgen, in association with Alzheimer’s Disease International, reveals that mo...

Sixth Annual Alzheimer’s Symposium Explores New Neuroscience Frontiers

World experts in neurodegenerative diseases gathered at Weill Cornell Medicine Sept. 25 for the sixth annual Appel Alzheimer’s Disease Research Institute Symposium, sponsored by the Appel Institute ...

Managing Money Problems in Alzheimer's Disease

Source: National Institute on Aging - Related MedlinePlus Pages: Alzheimer's Caregivers

When a Person with Alzheimer's Rummages and Hides Things

Source: National Institute on Aging - Related MedlinePlus Pages: Alzheimer's Caregivers

Drugs and Medications [171 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [banner home medical equipment]

Oxygen

Oxygen [banner home care of arizona ]

Oxygen

Rivastigmine [amneal pharmaceuticals llc]

These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM.   RIVAS...

Rivastigmine tartrate [sandoz inc]

These highlights do not include all the information needed to use Rivastigmine Tartrate Capsules safely and effectively. See full prescribing information for Rivastigmine Tartrate Capsules. Rivastigmi...

Rivastigmine tartrate [alembic pharmaceuticals limited]

These highlights do not include all the information needed to use Rivastigmine Tartrate Capsules USP safely and effectively. See full prescribing information for Rivastigmine Tartrate Capsules USP. Ri...

PubMed Articles [1166 Associated PubMed Articles listed on BioPortfolio]

When is Alzheimer's not dementia-Cochrane commentary on The National Institute on Ageing and Alzheimer's Association Research Framework for Alzheimer's Disease.

Early 2018 saw the release of new diagnostic guidance on Alzheimer's disease from the National Institute on Ageing and the Alzheimer's Association (NIA-AA). This proposed research framework represents...

A systems-based model of Alzheimer's disease.

The new National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease has been developed to accelerate drug discovery and offer a common structure and language...

Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease.

Alzheimer's disease (AD) is characterized by amyloid plaques and tau pathology (neurofibrillary tangles and neuropil threads). Amyloid plaques are primarily composed of aggregated and oligomeric β-am...

Is the risk of developing Alzheimer's disease really higher in rural areas? A multilevel longitudinal study of 261,669 Australians aged 45 years and older tracked over 11 years.

Cross-sectional studies of Alzheimer's disease tend to report higher risk in 'rural' areas. Multilevel longitudinal analysis of 261,669 participants in the Sax Institute's 45 and Up Study was conducte...

An updated Alzheimer hypothesis: Complement C3 and risk of Alzheimer's disease-A cohort study of 95,442 individuals.

We tested the hypothesis that low plasma complement C3 is observationally and genetically associated with high risk of Alzheimer's disease.

Clinical Trials [1869 Associated Clinical Trials listed on BioPortfolio]

Evaluating the Impact of Patient Photographs for Preventing Wrong-Patient Errors

This is a multi-site, cluster-randomized controlled trial to test the effectiveness of patient photographs displayed in electronic health record (EHR) systems to prevent wrong-patient orde...

Coordinating Center for Enhancing ADRD Caregiving

Established in 1995, Resources for Enhancing Alzheimer's Caregiver Health (REACH) is a unique, multi-site research program sponsored by the National Institute on Aging (NIA) and the Nation...

Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer's

Evaluate safety and toxicity/adverse events associated with delivery of low dose whole brain irradiation in patients with early Alzheimer's dementia according to the National Institute of ...

Dominantly Inherited Alzheimer Network (DIAN)

The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.

Noradrenergic Add-on Therapy With Guanfacine

NorAD is a clinical trial funded by the UK National Institute of Health Research. In this trial the investigators will assess whether a long-acting preparation of guanfacine, a drug used t...

Companies [1498 Associated Companies listed on BioPortfolio]

Banner Alzheimer's Institute

Banner Alzheimer's Institute (BAI) is a treatment and research facility dedicated to helping patients with memory and thinking problems. It offers clinical care for patients; provides education, refer...

Arizona Alzheimer's Consortium

The Arizona Alzheimer's Consortium is a laboratory without walls designed to leverage the strengths of its seven member institutions to promote the scientific understanding of Alzheimer's disease. The...

Banner Sun Health Research Institute

Banner Pharmacaps Inc.

Banner Pharmacaps Inc. is an emerging specialty pharmaceutical company dedicated to the research, development, and manufacturing of unique gelatin-based dosage forms. Banner has d...

Alzheimer's Research Foundation

The Fisher Center for Alzheimer's Research Foundation is a leading source of funding for Alzheimer's research. It serves Alzheimer's patients and their families to understand the causes of Alzheimer'...

More Information about "Banner Alzheimer's Institute" on BioPortfolio

We have published hundreds of Banner Alzheimer's Institute news stories on BioPortfolio along with dozens of Banner Alzheimer's Institute Clinical Trials and PubMed Articles about Banner Alzheimer's Institute for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Banner Alzheimer's Institute Companies in our database. You can also find out about relevant Banner Alzheimer's Institute Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record